Chiasma Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2014 | $70 M | No. 3 | $50 to $250 million | equity, options | SEC | |
| Jul 2012 | $10 M | No. 2 | $10 to $50 million | equity, options | SEC | |
| Jun 2011 | $5 M | No. 1 | $2 to $10 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Chiasma Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2015).
SEC Form D · Mar 2015
The industry group it chose in its notices: Biotechnology.
SEC Form D · Mar 2015
That is all the official record says: Chiasma Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
12 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| 7-MED Health Ventures LP | Venture capital | not stated | not stated | Held Series B1, C, D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Abingworth LLP | Fund or asset manager | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| F2 Capital I 2014 Ltd | Fund or asset manager | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Globeways Holdings Ltd | Company | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| LJ Skye Trustees Ltd. | Company | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| MPM Asset Management Investors BV4 LLC | Fund or asset manager | not stated | not stated | Held Series B-1, C, D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| MPM Bio IV NVS Strategic Fund LP | Fund or asset manager | not stated | not stated | Held Series B-1, C, D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| MPM BioVentures IV GmbH & Co. Beteiligungs KG | Venture capital | not stated | not stated | Held Series B-1, C, D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| MPM BioVentures IV GP LLC | Venture capital | not stated | not stated | Held Series B-1, C, D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| MPM BioVentures IV LLC | Venture capital | not stated | not stated | Held Series B-1, C, D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| MPM BioVentures IV QP LP | Venture capital | not stated | not stated | Held Series B-1, C, D and E preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Scott Minick | Person | not stated | not stated | Held Series B1 preferred stock, director (Form 3, 2015) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 21 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Chaime K. Orlev | Executive officer | Mar 2015 |
| Roni Mamluk | Executive officer | Mar 2015 |
| Fredric D. Price | Executive officer | Jul 2012 |
| Roni T. Mamluk | Executive officer | Jul 2012 |
| Sam T. Teichman | Executive officer | Jul 2012 |
| Roni J. Mamluk | Executive officer | Jul 2011 |
| Ansbert K. Gadicke | Director | Mar 2015 |
| Bard J. Geesaman | Director | Mar 2015 |
| David M. Stack | Director | Mar 2015 |
| Dror Brandwein | Director | Mar 2015 |
| John A. Scarlett | Director | Mar 2015 |
| Roni Mamluk | Director | Mar 2015 |
| Scott J. Minick | Director | Mar 2015 |
| Todd T. Foley | Director | Mar 2015 |
| Vincent J. Miles | Director | Mar 2015 |
| Fredric D. Price | Director | Jul 2012 |
| Scott T. Minick | Director | Jul 2012 |
About
Company in Waltham, United States.